Surprisingly, injecting DR-18 into tumor-bearing animals triggered the selective proliferation of stem-like TCF1+CD8+ T lymphocytes in tumors, as well as preferential differentiation towards polyfunctional T lymphocytes rather than an exhaustion phenotype. Here, CD8A is linked to neoplasm.